In a recent research at the Genetics and Epidemiology at Joslin, an unknown genetic variant has been identified, which increases the risk of coronary heart disease (CHD) in type 2 diabetic patients. According to the scientists, the finding has the potential to lead to the development of new treatments for CHD in diabetic patients.
In association with colleagues from the Harvard School of Public Health and research institutes in Italy, they conducted genome-wide analysis of 1,517 type 2 diabetic patients with CHD and 2,671 type 2 diabetic subjects without CHD. Their objective was to find out whether there were genetic determinants of CHD specific to diabetic patients. They compared the results to analyses of 737 non-diabetic participants with CHD and 1,637 non-diabetic participants without CHD.
A genetic variant in the region of the GLUL gene was found to have an association with an increased risk of CHD in type 2 diabetics.
The findings have been published in the Journal of the American Medical Association (JAMA).
Though all possible measures have been taken to ensure accuracy, reliability, timeliness and authenticity of the information; Onlymyhealth assumes no liability for the same. Using any information of this website is at the viewers’ risk. Please be informed that we are not responsible for advice/tips given by any third party in form of comments on article pages . If you have or suspect having any medical condition, kindly contact your professional health care provider.